Echo Therapeutics, Inc. | 2013 | FY | 3


At December 31, 2013, the Company had the following outstanding warrants:

 

   

Number of

Shares

Exercisable

   

Exercise

Price

 

Date of

Expiration

Outstanding warrants accounted for as derivative warrant liability:              
Granted to debt holder     400,000     $ 20.00   8/31/2017
Granted to debt holder     100,000       21.30   9/20/2017
Granted to debt holder     50,000       22.70   10/17/2017
Granted to debt holder     150,000       21.10   11/6/2017
Total outstanding warrants accounted for as derivative warrant liability     700,000            
Weighted average exercise price           $ 20.61    
Weighted average time to expiration in years                 3.72 years
                   
Outstanding warrants accounted for as equity:                  
Granted to investors in private placement of preferred stock     39,000     $ 7.50   2/28/2014
Granted to vendor     6,000       6.00   3/15/2014
Granted to investors in private placement     40,000       15.90   6/30/2014
Granted to investors in private placement     76,800       20.00   11/13/2014
Granted to placement agent in private placement     25,695       15.00   11/13/2014
Granted to investors in private placement     6,300       20.00   12/3/2014
Granted to investors in private placement     34,146       22.50   2/9/2015
Granted to placement agents in private placement     2,853       22.50   2/9/2015
Granted to investor in private placement     638       22.50   3/18/2015
Granted to investors in private placement     95,960       30.00   12/7/2014
Granted to investors in private placement of common and preferred stock     181,818       2.75   12/10/18
Total outstanding warrants accounted for as equity     509,211            
Weighted average exercise price           $ 14.21    
Weighted average time to expiration in years                 2.26 years
                   
Totals for all warrants outstanding:                  
Total     1,209,211            
Weighted average exercise price           $ 17.92    
Weighted average time to expiration in years                 3.11 years

 


us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock